Skip to main content

Published locations for HER2-negative breast cancer: Adding dalpiciclib to fulvestrant prolongs PFS in phase 3

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HER2-negative breast cancer: Adding dalpiciclib to fulvestrant prolongs PFS in phase 3

User login

  • Reset your password
  • /content/her2-negative-breast-cancer-adding-dalpiciclib-fulvestrant-prolongs-pfs-phase-3
  • /hematology-oncology/article/250066/breast-cancer/her2-negative-breast-cancer-adding-dalpiciclib
  • /breast-cancer-icymi/article/250066/breast-cancer/her2-negative-breast-cancer-adding-dalpiciclib